We’re thrilled to announce that ReNewVax has been shortlisted as one of the finalists to present a pitch at the 2023 BIO International Convention in Boston, Massachusetts. 

Taking place from 5th –8th June, the BIO International Convention is the world’s largest biotechnology gathering. It brings together thousands of biotech groups, academic and research institutions, and related organisations to recognise the true value of the breakthrough work being done across the globe in this field.

Our Chief Scientific Officer Dr. Marie O’Brien will present our pitch as part of the Start-Up Stadium on Thursday 8 June, joining eight other companies showcasing their work from 11am-1pm.

We can’t wait to join the 14,000+ attendees in the fight for the current and future state of biotech. 

#StandUpForScience #BIO2023